Showing results (291-300 of 592) with videos related to
Sort By:
Pageof 60
Cancers|May 25, 2024
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative ReviewFilippo Lococo, Galal Ghaly, Marco Chiappetta, et al.Plos One|June 19, 2015
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary CancersLuisa Carbognin, Sara Pilotto, Michele Milella, et al.La Radiologia Medica|May 6, 2021
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Anna Merlotti, Alessio Bruni, Paolo Borghetti, et al.Future Oncology (London, England)|January 10, 2015
Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?Sebastiano Buti, Chiara Ciccarese, Daniele Zanoni, et al.Critical Reviews in Oncology/Hematology|September 8, 2014
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysisEmilio Bria, Francesco Massari, Francesca Maines, et al.Histology and Histopathology|March 8, 2014
Adenocarcinoma of the paraurethral glands: a case reportFrancesco Massari, Chiara Ciccarese, Alessandra Modena, et al.Cancers|August 28, 2020
Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for CliniciansFabio Marazzi, Armando Orlandi, Stefania Manfrida, et al.Cancer Treatment Reviews|April 10, 2021
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients' data from 3 phase III studiesLisa Salvatore, Emilio Bria, Isabella Sperduti, et al.Expert Opinion on Biological Therapy|January 31, 2017
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for researchValentina Zambonin, Alessandro De Toma, Luisa Carbognin, et al.Anticancer Research|December 7, 2016
Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral ChemotherapyMaria Ornella Nicoletto, Alessandra Casarin, Alessandra Baldoni, et al.Pageof 60